Unknown NA INTERVENTIONAL 2-arm NCT03609268

Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma

Effects of Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma: a Prospective, Randomized Controlled Study

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions Microwave Ablation Recurrent Hepatocellular Carcinoma Stereotactic Body Radiotherapy

Interventions microwave ablation (MWA) stereotactic body radiotherapy (SBRT)

Updated 5 times since 2018 Last updated: Jul 24, 2018 Started: Jun 30, 2018 Primary completion: May 31, 2021 Completion: May 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Microwave Ablation and Recurrent Hepatocellular Carcinoma, this trial is ongoing. The trial is conducted by Second Affiliated Hospital, School of Medicine, Zhejiang University and has accumulated 5 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Aug 2018 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China